0 Evaluaciones
ID

16428

Descripción

A Study of Pertuzumab in Participants With Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02491892

Link

https://clinicaltrials.gov/show/NCT02491892

Palabras clave

Versiones (2)
  1. 16/7/16 16/7/16 -
  2. 17/9/21 17/9/21 -
Subido en

16 de julio de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

    Sin comentarios

    Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

    Eligibility Breast Cancer NCT02491892

    Inglés

    Eligibility Breast Cancer NCT02491892

    1 formularios  
    Inclusion Criteria
    Descripción

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    females at least 18 years of age
    Descripción

    Gender | Age

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0079399
    UMLS CUI [2]
    C0001779
    histologically-confirmed metastatic breast cancer with low her2 expression and at least one measurable lesion according to response evaluation criteria in solid tumors (recist)
    Descripción

    Carcinoma breast stage IV | HER-2 protein overexpression low | Measurable lesion

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0278488
    UMLS CUI [2,1]
    C3888504
    UMLS CUI [2,2]
    C0205251
    UMLS CUI [3]
    C1513041
    karnofsky performance status at least 80%
    Descripción

    Karnofsky Performance Status

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0206065
    disease progression on/after up to 2 different chemotherapy regimens, including an anthracycline-containing therapy
    Descripción

    Chemotherapy Quantity | Anthracycline Antibiotics | Disease Progression

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0392920
    UMLS CUI [1,2]
    C1265611
    UMLS CUI [2]
    C0003234
    UMLS CUI [3]
    C0242656
    left ventricular ejection fraction (lvef) at least 50%
    Descripción

    Left ventricular ejection fraction

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0428772
    adequate liver function
    Descripción

    Liver function

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0232741
    Exclusion Criteria
    Descripción

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    pleural effusions, ascites, or bone lesions as the only manifestation(s) of cancer
    Descripción

    Malignant Neoplasm Manifestation of | Pleural effusion disorder | Ascites | Bone lesion

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0006826
    UMLS CUI [1,2]
    C1280464
    UMLS CUI [2]
    C0032227
    UMLS CUI [3]
    C0003962
    UMLS CUI [4]
    C0238792
    pulmonary or central nervous system (cns) metastases
    Descripción

    Secondary malignant neoplasm of lung | CNS metastases

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0153676
    UMLS CUI [2]
    C0686377
    chemotherapy, radiotherapy, or immunotherapy within 4 weeks; or hormone therapy within 2 weeks of day 1
    Descripción

    Chemotherapy | Therapeutic radiology procedure | Immunotherapy | Hormone Therapy

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0392920
    UMLS CUI [2]
    C1522449
    UMLS CUI [3]
    C0021083
    UMLS CUI [4]
    C0279025
    previous treatment with any drug that targets the her2 receptor family
    Descripción

    Pharmaceutical Preparation Targeting erbB-2 Receptor

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0013227
    UMLS CUI [1,2]
    C1521840
    UMLS CUI [1,3]
    C0069515
    previous treatment with corticosteroids as cancer therapy
    Descripción

    cancer treatment | Adrenal Cortex Hormones

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0920425
    UMLS CUI [2]
    C0001617
    history of significant cardiac disease
    Descripción

    Heart Disease Significant

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0018799
    UMLS CUI [1,2]
    C0750502
    major surgery or trauma within 4 weeks of day 1
    Descripción

    major surgery | Major trauma

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0679637
    UMLS CUI [2]
    C0332677
    pregnant or lactating women
    Descripción

    Pregnancy | Breast Feeding

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    UMLS CUI [2]
    C0006147
    Volver a la parte superior de la página

    Similar models

    Eligibility Breast Cancer NCT02491892

    1 formularios
    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de datos
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Gender | Age
    Item
    females at least 18 years of age
    boolean
    C0079399 (UMLS CUI [1])
    C0001779 (UMLS CUI [2])
    Carcinoma breast stage IV | HER-2 protein overexpression low | Measurable lesion
    Item
    histologically-confirmed metastatic breast cancer with low her2 expression and at least one measurable lesion according to response evaluation criteria in solid tumors (recist)
    boolean
    C0278488 (UMLS CUI [1])
    C3888504 (UMLS CUI [2,1])
    C0205251 (UMLS CUI [2,2])
    C1513041 (UMLS CUI [3])
    Karnofsky Performance Status
    Item
    karnofsky performance status at least 80%
    boolean
    C0206065 (UMLS CUI [1])
    Chemotherapy Quantity | Anthracycline Antibiotics | Disease Progression
    Item
    disease progression on/after up to 2 different chemotherapy regimens, including an anthracycline-containing therapy
    boolean
    C0392920 (UMLS CUI [1,1])
    C1265611 (UMLS CUI [1,2])
    C0003234 (UMLS CUI [2])
    C0242656 (UMLS CUI [3])
    Left ventricular ejection fraction
    Item
    left ventricular ejection fraction (lvef) at least 50%
    boolean
    C0428772 (UMLS CUI [1])
    Liver function
    Item
    adequate liver function
    boolean
    C0232741 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    Malignant Neoplasm Manifestation of | Pleural effusion disorder | Ascites | Bone lesion
    Item
    pleural effusions, ascites, or bone lesions as the only manifestation(s) of cancer
    boolean
    C0006826 (UMLS CUI [1,1])
    C1280464 (UMLS CUI [1,2])
    C0032227 (UMLS CUI [2])
    C0003962 (UMLS CUI [3])
    C0238792 (UMLS CUI [4])
    Secondary malignant neoplasm of lung | CNS metastases
    Item
    pulmonary or central nervous system (cns) metastases
    boolean
    C0153676 (UMLS CUI [1])
    C0686377 (UMLS CUI [2])
    Chemotherapy | Therapeutic radiology procedure | Immunotherapy | Hormone Therapy
    Item
    chemotherapy, radiotherapy, or immunotherapy within 4 weeks; or hormone therapy within 2 weeks of day 1
    boolean
    C0392920 (UMLS CUI [1])
    C1522449 (UMLS CUI [2])
    C0021083 (UMLS CUI [3])
    C0279025 (UMLS CUI [4])
    Pharmaceutical Preparation Targeting erbB-2 Receptor
    Item
    previous treatment with any drug that targets the her2 receptor family
    boolean
    C0013227 (UMLS CUI [1,1])
    C1521840 (UMLS CUI [1,2])
    C0069515 (UMLS CUI [1,3])
    cancer treatment | Adrenal Cortex Hormones
    Item
    previous treatment with corticosteroids as cancer therapy
    boolean
    C0920425 (UMLS CUI [1])
    C0001617 (UMLS CUI [2])
    Heart Disease Significant
    Item
    history of significant cardiac disease
    boolean
    C0018799 (UMLS CUI [1,1])
    C0750502 (UMLS CUI [1,2])
    major surgery | Major trauma
    Item
    major surgery or trauma within 4 weeks of day 1
    boolean
    C0679637 (UMLS CUI [1])
    C0332677 (UMLS CUI [2])
    Pregnancy | Breast Feeding
    Item
    pregnant or lactating women
    boolean
    C0032961 (UMLS CUI [1])
    C0006147 (UMLS CUI [2])
    Volver a la parte superior de la página 

    Ayuda

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial